"Tumor-free survival" Does Not Outweigh the Adverse Effects of Anti-EGFR Therapy and Chemotherapy in Patients With NSCLC.
Mei-Mei ZhengYi-Long WuPublished in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (2024)